Veradermics’ hair loss drug succeeds in late-stage trial
statnews.com • • business
Key Points:
- Veradermics announced that its oral hair loss medication, VDPHL01, successfully promoted hair growth in a late-stage clinical trial.
- Men taking the drug once or twice daily for six months grew between 30 and 33 additional hairs per square centimeter, compared to about seven hairs in the placebo group.
- Participant satisfaction ranged from 79% to 86%, while 72% to 84% of clinical trial investigators also observed improvement.
- The positive results have been well received by Veradermics’ CEO, dermatologist Reid Waldman.
